Patents by Inventor Zhongsheng ZHANG

Zhongsheng ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them
    Patent number: 11584744
    Abstract: The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 21, 2023
    Assignee: University of Washington
    Inventors: Erkang Fan, Zhongsheng Zhang, Wenlin Huang, Frederick S. Buckner
  • INHIBITORS OF TYPE l METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM
    Publication number: 20210155617
    Abstract: The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
    Type: Application
    Filed: June 22, 2018
    Publication date: May 27, 2021
    Inventors: Erkang FAN, Zhongsheng ZHANG, Wenlin HUANG, Frederick S. BUCKNER
  • Specific inhibitors of methionyl-tRNA synthetase
    Patent number: 10913736
    Abstract: The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: February 9, 2021
    Assignee: University of Washington
    Inventors: Frederick S. Buckner, Ximena Barros Alvarez, Erkang Fan, John Robert Gillespie, Wilhelmus G.J. Hol, Wenlin Huang, Cho Yeow Koh, Ranae M. Ranade, Sayaka Shibata, Christophe L.M. Verlinde, Zhongsheng Zhang
  • 5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum
    Patent number: 9956214
    Abstract: The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: May 1, 2018
    Assignee: University of Washington Through its Center for Commercialization
    Inventors: Erkang Fan, Wesley C. Van Voorhis, Zhongsheng Zhang, Wenlin Huang, Kayode K. Ojo
  • SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE
    Publication number: 20170275279
    Abstract: The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
    Type: Application
    Filed: August 21, 2015
    Publication date: September 28, 2017
    Inventors: Frederick S. BUCKNER, Ximena Barros ALVAREZ, Erkang FAN, John Robert GILLESPIE, Wilhelmus G.J. HOL, Wenlin HUANG, Cho Yeow KOH, Ranae M. RANADE, Sayaka SHIBATA, Christophe L.M. VERLINDE, Zhongsheng ZHANG
  • 5-AMINOPYRAZOLE-4-CARBOXAMIDE INHIBITORS OF CDPK1 FROM T. GONDII AND C. PARVUM
    Publication number: 20170056389
    Abstract: The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.
    Type: Application
    Filed: November 15, 2016
    Publication date: March 2, 2017
    Inventors: Erkang FAN, Wesley C. VAN VOORHIS, Zhongsheng ZHANG, Wenlin HUANG, Kayode K. OJO
  • 5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from and
    Patent number: 9518026
    Abstract: The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: December 13, 2016
    Assignee: University of Washington Through its Center For Commercialization
    Inventors: Erkang Fan, Wesley C. Van Voorhis, Zhongsheng Zhang, Wenlin Huang, Kayode K. Ojo
  • 5-AMINOPYRAZOLE-4-CARBOXAMIDE INHIBITORS OF CDPK1 FROM T. GONDII AND C. PARVUM
    Publication number: 20160090362
    Abstract: The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.
    Type: Application
    Filed: May 20, 2014
    Publication date: March 31, 2016
    Inventors: Erkang FAN, Wesley C. VAN VOORHIS, Zhongsheng ZHANG, Wenlin HUANG,, Kayode K. OJO